These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

911 related articles for article (PubMed ID: 29329643)

  • 1. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
    Suzuki H; Yasutake J; Makita Y; Tanbo Y; Yamasaki K; Sofue T; Kano T; Suzuki Y
    Kidney Int; 2018 Mar; 93(3):700-705. PubMed ID: 29329643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
    Zhao L; Peng L; Yang D; Chen S; Lan Z; Zhu X; Yuan S; Chen G; Liu Y; Liu H
    Clin Immunol; 2020 Aug; 217():108483. PubMed ID: 32479989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
    Wada Y; Matsumoto K; Suzuki T; Saito T; Kanazawa N; Tachibana S; Iseri K; Sugiyama M; Iyoda M; Shibata T
    PLoS One; 2018; 13(11):e0206865. PubMed ID: 30388165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy.
    Yasutake J; Suzuki Y; Suzuki H; Hiura N; Yanagawa H; Makita Y; Kaneko E; Tomino Y
    Nephrol Dial Transplant; 2015 Aug; 30(8):1315-21. PubMed ID: 26109484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy.
    Sugiyama M; Wada Y; Kanazawa N; Tachibana S; Suzuki T; Matsumoto K; Iyoda M; Honda H; Shibata T
    PLoS One; 2020; 15(4):e0232194. PubMed ID: 32324811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy.
    Lee M; Suzuki H; Kato R; Fukao Y; Nakayama M; Kano T; Makita Y; Suzuki Y
    CEN Case Rep; 2021 Feb; 10(1):17-22. PubMed ID: 32676896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.
    Rizk DV; Saha MK; Hall S; Novak L; Brown R; Huang ZQ; Fatima H; Julian BA; Novak J
    J Am Soc Nephrol; 2019 Oct; 30(10):2017-2026. PubMed ID: 31444275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy.
    Zhang K; Li Q; Zhang Y; Shang W; Wei L; Li H; Gao S; Yan T; Jia J; Liu Y; Lin S
    Kidney Blood Press Res; 2019; 44(5):1196-1206. PubMed ID: 31574506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunostaining for galactose-deficient immunoglobulin A is not specific for primary immunoglobulin A nephropathy.
    Cassol CA; Bott C; Nadasdy GM; Alberton V; Malvar A; Nagaraja HN; Nadasdy T; Rovin BH; Satoskar AA
    Nephrol Dial Transplant; 2020 Dec; 35(12):2123-2129. PubMed ID: 31369128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular galactose-deficient IgA1 expression analysis in pediatric patients with glomerular diseases.
    Ishiko S; Horinouchi T; Fujimaru R; Shima Y; Kaito H; Tanaka R; Ishimori S; Kondo A; Nagai S; Aoto Y; Sakakibara N; Nagano C; Yamamura T; Yoshimura M; Nakanishi K; Fujimura J; Kamiyoshi N; Nagase H; Yoshikawa N; Iijima K; Nozu K
    Sci Rep; 2020 Aug; 10(1):14026. PubMed ID: 32820208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary IgA Vasculitis with Nephritis in a Patient with Rheumatoid Arthritis Diagnosed by Anti-galactose-deficient IgA1 Immunostaining.
    Karasawa K; Iwabuchi Y; Kyoda M; Akihisa T; Yamaguchi E; Suzuki S; Ogura S; Takabe T; Miyabe Y; Kamiyama T; Nakano M; Manabe S; Kamiyama M; Akiyama K; Sato M; Uchida K; Nitta K; Moriyama T
    Intern Med; 2019 Sep; 58(17):2551-2554. PubMed ID: 31178497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma galactose-deficient immunoglobulin A1 and loss of kidney function in patients with immunoglobulin A vasculitis nephritis.
    Zhang X; Xie X; Shi S; Liu L; Lv J; Zhang H
    Nephrol Dial Transplant; 2020 Dec; 35(12):2117-2123. PubMed ID: 31377786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular Galactose-Deficient IgA1(KM55) Positive May Predict Poorer Prognosis in Coexisting Primary Membranous Nephropathy and IgA Nephropathy Patients.
    Cheng W; Wang G; Guo W; Sun L; Xu X; Dong H; Ye S; Geng Y; Cheng H
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galactose-Deficient IgA1-Specific Antibody Recognizes GalNAc-Modified Unique Epitope on Hinge Region of IgA1.
    Yamasaki K; Suzuki H; Yasutake J; Yamazaki Y; Suzuki Y
    Monoclon Antib Immunodiagn Immunother; 2018 Dec; 37(6):252-256. PubMed ID: 30570353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression.
    Martín-Penagos L; Fernández-Fresnedo G; Benito-Hernández A; Mazón J; de Cos M; Oviedo MV; San Segundo D; López-Hoyos M; Gómez-Román J; Ruiz JC; Rodrigo E
    Nefrologia (Engl Ed); 2021; 41(3):311-320. PubMed ID: 33741175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
    Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
    Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of left renal vein entrapment with IgA nephropathy and Henoch-Schönlein purpura nephritis.
    Wang F; Zhu H; Bao S; Qi H; Xu L; Liu X; Zhai C; Yang X; Wang R
    Ren Fail; 2022 Dec; 44(1):1519-1527. PubMed ID: 36069515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transplant immunoglobulin A deposition and nephropathy in allografts.
    Sofue T; Suzuki H; Ueda N; Kushida Y; Minamino T
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():4-9. PubMed ID: 29968406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study.
    Bagchi S; Lingaiah R; Mani K; Barwad A; Singh G; Balooni V; Bhowmik D; Agarwal SK
    PLoS One; 2019; 14(3):e0214256. PubMed ID: 30917188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune characteristics of renal allograft donors with mesangial IgA deposition.
    Wang Z; Zhang X; Han W; Yu G; Ying Z; Xu X; Wang M; Zhou X; Lv J; Zhang H
    Int Immunopharmacol; 2021 Feb; 91():107282. PubMed ID: 33370682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.